Development of donor-specific isohemagglutinins following pediatric ABO-incompatible heart transplantation

American Journal of Transplantation

Volumn 12, Issue 4, 2012, Pages 888-895

  Conway, Jennifer ^a   Manlhiot, C ^a   Allain Rooney, T ^a   McCrindle, B W ^a   Lau, W ^a   Dipchand, A I ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

ABO incompatibility; B lymphocyte; Cardiovascular transplantation; Isoantibodies; Pediatric

Indexed keywords

BLOOD GROUP A ANTIBODY; BLOOD GROUP B ANTIBODY; DONOR SPECIFIC ISOHEMAGGLUTININ; HEMAGGLUTININ; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; BLOOD GROUP A; BLOOD GROUP AB; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP B; BLOOD GROUP O; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CARDIOMYOPATHY; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; FEMALE; FOLLOW UP; GRAFT DYSFUNCTION; GRAFT NECROSIS; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART GRAFT; HEART TRANSPLANTATION; HLA SYSTEM; HUMAN; INFANT; LONGITUDINAL STUDY; MALE; NEWBORN; OBSERVATIONAL STUDY; ORGAN DONOR; OUTCOME ASSESSMENT; PEDIATRIC SURGERY; POST TREATMENT SURVIVAL; PRIORITY JOURNAL; RISK FACTOR; SENSITIZATION;

ABO BLOOD-GROUP SYSTEM; ANTIBODIES; B-LYMPHOCYTES; BLOOD GROUP INCOMPATIBILITY; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART TRANSPLANTATION; HEMAGGLUTININS; HUMANS; IMMUNE TOLERANCE; INFANT; INFANT, NEWBORN; LONGITUDINAL STUDIES; MALE; RISK FACTORS; TISSUE DONORS;

EID: 84859435350     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03910.x     Document Type: Article

References (22)

1. West LJ, Pollock-Barziv SM, Dipchand AI, et al. ABO-incompatible heart transplantation in infants. N Engl JMed. 2001; 344: 793-800. (Pubitemid 32222156)
2. Daebritz SH, Schmoeckel M, Mair H, et al. Blood type incompatible cardiac transplantation in young infants. Eur J Cardiothorac Surg. 2007; 31: 339-343; discussion 43.
3. Dipchand AI, Pollock Barziv SM, Manlhiot C, West LJ, Vandervliet M, McCrindle BW. Equivalent outcomes for pediatric heart transplantation recipients: ABO-blood group incompatible versus ABO compatible. Am J Transplant 2009; 10: 389-397.
4. Roche SL, Burch M, O'Sullivan J, et al. Multicenter experience of ABO-incompatible pediatric cardiac transplantation. Am J Transplant 2008; 8: 208-215.
5. Rodriguez RJ, Addonizio LJ, Lamour JM, et al. Pediatric heart transplantation across ABO blood type barriers: A case study. Prog Transplant 2005; 15: 161-165.
6. West LJ, Karamlou T, Dipchand AI, Pollock-BarZiv SM, Coles JG, McCrindle BW. Impact on outcomes after listing and transplantation, of a strategy to accept ABO blood group-incompatible donor hearts for neonates and infants. J Thorac Cardiovasc Surg 2006; 131: 455-461. (Pubitemid 43121571)
7. Pollock-BarZiv SM, McCrindle BW, West LJ, Manlhiot C, VanderVliet M, Dipchand AI. Competing outcomes after neonatal and infantwait-listing for heart transplantation. J Heart Lung Transplant 2007; 26: 980-985.
8. Fong SW, Qaqundah BY, Taylor WF. Developmental patterns of ABO isoagglutinins in normal children correlated with the effects of age, sex, and maternal isoagglutinins. Transfusion 1974; 14: 551-559.
9. Auf der Maur C, Hodel M, Nydegger UE, Rieben R. Age dependency of ABO histo-blood group antibodies: Reexamination of an old dogma. Transfusion 1993; 33: 915-918. (Pubitemid 24004751)
10. Fan X, Ang A, Pollock-Barziv SM, et al. Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation. Nat Med 2004; 10: 1227-1233. (Pubitemid 39540440)
11. Bucin D, Johansson S, Lindberg LO. Heart transplantation across antibodies against human leukocyte antigen and ABO-posttransplant follow-up of donor reactive antibodies. Xenotransplantation 2006; 13: 101-104.
12. Bucin D, Johansson S, Malm T, et al. Heart transplantation across the antibodies against HLA and ABO. Transpl Int 2006; 19: 239-244.
13. Pollock-Barziv SM, McCrindle BW, West LJ, Dipchand AI. Waiting before birth: Outcomes after fetal listing for heart transplantation. Am J Transplant 2008; 8: 412-418.
14. Liu YJ, Chen W, Wu KW, Broadberry RE, Lin M. The development of ABO isohemagglutinins in Taiwanese. Hum Hered 1996; 46: 181-184. (Pubitemid 26185326)
15. Rydberg L. ABO-incompatibility in solid organ transplantation. Transfus Med 2001; 11: 325-342. (Pubitemid 32771925)
16. Di Filippo S, Girnita A, Webber SA, et al. Impact of ELISA-detected anti-HLA antibodies on pediatric cardiac allograft outcome. Hum Immunol 2005; 66: 513-518. (Pubitemid 40797549)
17. Holt DB, Lublin DM, Phelan DL, et al. Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy. J Heart Lung Transplant 2007; 26: 876-882. (Pubitemid 47371287)
18. Reed EF, Demetris AJ, Hammond E, et al. Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant 2006; 25: 153-159. (Pubitemid 43156365)
19. Wu A, Buhler LH, Cooper DK. ABO-incompatible organ and bone marrow transplantation: Current status. Transpl Int 2003; 16: 291-299. (Pubitemid 36733739)
20. Platt JL. A perspective on xenograft rejection and accommodation. Immunol Rev 1994; 141: 127-149.
21. Lin Y, Vandeputte M, Waer M. Accommodation and T-independent B cell tolerance in rats with long term surviving hamster heart xenografts. J Immunol 1998; 160: 369-375. (Pubitemid 28116751)
22. Lin SS, Hanaway MJ, Gonzalez-Stawinski GV, et al. The role of anti-Galalpha1-3Gal antibodies in acute vascular rejection and accommodation of xenografts. Transplantation 2000; 70: 1667-1674. (Pubitemid 32064818)